het optimaliseren van de voorbereiding voor sigmoidoscopie in de regio; Moviprep versus Bisacodyl/klysma, een enkelblind gerandomiseerd onderzoek

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-011248-21-NL

Enrollment

200

Registered

2009-07-03

Start date

2009-06-29

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel preparation for sigmoidoscopy.

Interventions

Pharmaceutical Form:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult, outpatients, capable of understanding the trial and to give imformed consent Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - Pregnancy - Breastfeeding - Immobility - Emergency endoscopy - Inflammatory Bowel Disease - G6PD-deficientie - Cardiac failure class III en IV - Fenylketonurie

Design outcomes

Primary

Measure	Time frame
Main Objective: Prove that Moviprep is a better bowelpreparation than the standard preparation which consists of Bisacodyl and a Phosphate enema;Secondary Objective: Prove that Moviprep is well accepted by patients in terms of handling and side effects;Primary end point(s): A higher percentage of adequately cleaned bowels for sigmoidoscopy	—

Countries

Netherlands

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026